Procurement Summary
Country : United Kingdom
Summary : Uclh-6630 - Lecanemab Homecare Service
Deadline : 26 Mar 2025
Other Information
Notice Type : Tender
TOT Ref.No.: 115802471
Document Ref. No. : CF-2881000D0O000000rwimUAA
Financier : Self Financed
Purchaser Ownership : Public
Tender Value : GBP 816000
Purchaser's Detail
Name :Login to see tender_details
Address : Login to see tender_details
Email : Login to see tender_details
Login to see detailsTender Details
The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.
Location Of Contract : NW1 2PB
Industry : Pharmacy services - 85149000
Value Of Contract : £81, 600 to £816, 000
Published Date : 5 March 2025
Closing Date : 26 March 2025
Documents
Tender Notice